Indian drugmaker Mankind Pharma reported a 39% surge in second-quarter profit to 7.11 billion rupees, driven by strong demand for chronic therapies like diabetes and cardiac treatments.
India's Mankind Pharma may raise condom prices if Middle East conflict keeps oil costs high, citing petroleum-linked raw material expenses. Separately, the company is expanding its generic semaglutide
Mankind Pharma reported a 30% rise in Q4 profit to 5.54 billion rupees, driven by demand for chronic therapies and consumer healthcare products. Its domestic formulations business grew 11.5%, outpacin
ChemBrief